The CXCR4 Antagonist AMD3100 Has Dual Effects, Initially Enhancing and Later Inhibiting Survival and Proliferation, in Myeloid Leukemia Cells in Vitro.

被引：0
|
作者：
Kim, Ha-Yon [1 ]
Hwang, Ji-Young [1 ]
Kim, Seong-Woo [1 ]
Yun, Gak-Won [1 ]
Yang, Young-Joon [1 ]
Lee, Hyo-Jin [1 ]
Jo, Deog-Yeon [1 ,2 ]
机构：
[1] Chungnam Natl Univ, Dept Internal Med, Sch Med, Div Hematol Oncol, Taejon, South Korea
[2] Chungnam Natl Univ, Canc Res Inst, Taejon, South Korea
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：685 / 686
页数：2
相关论文
共 50 条
  • [31] Dual Effect of AMD3100, a CXCR4 Antagonist, on Bleomycin-Induced Lung Inflammation (Retraction of vol 178, pg 5888, 2007)
    Watanabe, Masaki
    Matsuyama, Wataru
    Shirahama, Yuko
    Mitsuyama, Hideo
    Oonakahara, Ken-ichi
    Noma, Satoshi
    Higashimoto, Ikkou
    Osame, Mitsuhiro
    Arimura, Kimiyoshi
    JOURNAL OF IMMUNOLOGY, 2008, 181 (09): : 6670 - 6670
  • [32] Suppression of X4- and dual-tropic HIV-1 variants during a short course of monotherapy with the CXCR4 antagonist AMD3100
    Fransen, S
    Huang, W
    Toma, J
    Bridger, G
    Calandra, G
    Whitcomb, JM
    Petropoulos, CJ
    ANTIVIRAL THERAPY, 2004, 9 (04) : U26 - U26
  • [33] AMD3100, an antagonist of CXCR4 and mobilizer of myeloid progenitor cells, is a potent mobilizer of competitive repopulating long term marrow self-renewing stem cells in mice.
    Broxmeyer, HE
    Hangoc, G
    Cooper, S
    Li, XX
    Bridger, G
    Clapp, DW
    BLOOD, 2002, 100 (11) : 609A - 609A
  • [34] Antitumor effect of CXCR4 antagonist AMD3100 on the tumorigenic cell line of BHP10-3 papillary thyroid cancer cells
    Jung, Young Ho
    Lee, Doh Young
    Cha, Wonjae
    Kim, Bo Hae
    Sung, Myung-Whun
    Kim, Kwang Hyun
    Ahn, Soon-Hyun
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (10): : 1479 - 1486
  • [35] AMD3100, a CXCR4 antagonist, augments mobilization and incorporation of bone marrow-derived endothelial progenitor cells into sites of myocardial neovascularization
    Iwakura, A
    Luedemann, C
    Kusano, K
    Takenaka, H
    Eaton, E
    Bridger, G
    Losordo, DW
    CIRCULATION, 2003, 108 (17) : 159 - 159
  • [36] The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells
    D. Yoshida
    K Koketshu
    R. Nomura
    A. Teramoto
    Journal of Neuro-Oncology, 2010, 100 : 51 - 64
  • [37] The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells
    Yoshida, D.
    Koketshu, K.
    Nomura, R.
    Teramoto, A.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 100 (01) : 51 - 64
  • [38] The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics
    Fruehauf, Stefan
    Seeger, Timon
    Maier, Patrick
    Li, Li
    Weinhardt, Stephan
    Laufs, Stephanie
    Wagner, Wolfgang
    Eckstein, Volker
    Bridger, Gary
    Calandra, Gary
    Wenz, Frederick
    Zeller, W. Jens
    Goldschmidt, Hartmut
    Ho, Anthony D.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (08) : 1052 - 1059
  • [39] CXCR4 antagonist AMD3100 enhances the response of MDA-MB-231 triple-negative breast cancer cells to ionizing radiation
    Zhou, K. X.
    Xie, L. H.
    Peng, X.
    Guo, Q. M.
    Wu, Q. Y.
    Wang, W. H.
    Zhang, G. L.
    Wu, J. F.
    Zhang, G. J.
    Du, C. W.
    CANCER LETTERS, 2018, 418 : 196 - 203
  • [40] Blockade of the CXCL12/CXCR4 axis with AMD3100 induces multimodal antitumor effects in murine ovarian cancer and prolongs survival
    Kashiwagi, Satoshi
    Righi, Elda
    Yuan, Jianping
    Santosuosso, Michael
    Ingraham, Rachel
    Orsulic, Sandra
    Birrer, Michael
    Penson, Richard
    Dranoff, Glenn
    Poznansky, Mark C.
    CANCER RESEARCH, 2011, 71
12345